138 related articles for article (PubMed ID: 28656205)
1. Role of PKA in the process of neonatal cardiomyocyte hypertrophy induced by urotensin II.
Xu J; Han Q; Shi H; Liu W; Chu T; Li H
Int J Mol Med; 2017 Aug; 40(2):499-504. PubMed ID: 28656205
[TBL] [Abstract][Full Text] [Related]
2. Urotensin II induction of neonatal cardiomyocyte hypertrophy involves the CaMKII/PLN/SERCA 2a signaling pathway.
Shi H; Han Q; Xu J; Liu W; Chu T; Zhao L
Gene; 2016 May; 583(1):8-14. PubMed ID: 26930364
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor alpha protects heart cultures against hypoxic damage via activation of PKA and phospholamban to prevent calcium overload.
El-Ani D; Philipchik I; Stav H; Levi M; Zerbib J; Shainberg A
Can J Physiol Pharmacol; 2014 Nov; 92(11):917-25. PubMed ID: 25349921
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II and the JNK pathway mediate urotensin II expression in response to hypoxia in rat cardiomyocytes.
Chiu CZ; Wang BW; Shyu KG
J Endocrinol; 2014 Mar; 220(3):233-46. PubMed ID: 24481965
[TBL] [Abstract][Full Text] [Related]
5. Phospholamban pentamers attenuate PKA-dependent phosphorylation of monomers.
Wittmann T; Lohse MJ; Schmitt JP
J Mol Cell Cardiol; 2015 Mar; 80():90-7. PubMed ID: 25562800
[TBL] [Abstract][Full Text] [Related]
6. Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation.
Funk F; Kronenbitter A; Hackert K; Oebbeke M; Klebe G; Barth M; Koch D; Schmitt JP
Cardiovasc Res; 2023 Jul; 119(7):1568-1582. PubMed ID: 36869774
[TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV alleviates hypoxia/reoxygenation-induced neonatal rat cardiomyocyte injury via the protein kinase a pathway.
Zhang DW; Bian ZP; Xu JD; Wu HF; Gu CR; Zhou B; Chen XJ; Yang D
Pharmacology; 2012; 90(1-2):95-101. PubMed ID: 22797566
[TBL] [Abstract][Full Text] [Related]
8. Urotensin II induction of adult cardiomyocytes hypertrophy involves the Akt/GSK-3beta signaling pathway.
Gruson D; Ginion A; Decroly N; Lause P; Vanoverschelde JL; Ketelslegers JM; Bertrand L; Thissen JP
Peptides; 2010 Jul; 31(7):1326-33. PubMed ID: 20416349
[TBL] [Abstract][Full Text] [Related]
9. Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy.
Tzanidis A; Hannan RD; Thomas WG; Onan D; Autelitano DJ; See F; Kelly DJ; Gilbert RE; Krum H
Circ Res; 2003 Aug; 93(3):246-53. PubMed ID: 12842917
[TBL] [Abstract][Full Text] [Related]
10. Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal rats.
Zou Y; Nagai R; Yamazaki T
FEBS Lett; 2001 Nov; 508(1):57-60. PubMed ID: 11707268
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.
Yokoe S; Asahi M; Takeda T; Otsu K; Taniguchi N; Miyoshi E; Suzuki K
Glycobiology; 2010 Oct; 20(10):1217-26. PubMed ID: 20484118
[TBL] [Abstract][Full Text] [Related]
12. Interaction between A-kinase anchoring protein 5 and protein kinase A mediates CaMKII/HDAC signaling to inhibit cardiomyocyte hypertrophy after hypoxic reoxygenation.
Zhang X; Wang Q; Wang Z; Zhang H; Zhu F; Ma J; Wang W; Chen Z; Wang H
Cell Signal; 2023 Mar; 103():110569. PubMed ID: 36565899
[TBL] [Abstract][Full Text] [Related]
13. UCR1C is a novel activator of phosphodiesterase 4 (PDE4) long isoforms and attenuates cardiomyocyte hypertrophy.
Wang L; Burmeister BT; Johnson KR; Baillie GS; Karginov AV; Skidgel RA; O'Bryan JP; Carnegie GK
Cell Signal; 2015 May; 27(5):908-22. PubMed ID: 25683917
[TBL] [Abstract][Full Text] [Related]
14. Phospholamban degradation is induced by phosphorylation-mediated ubiquitination and inhibited by interaction with cardiac type Sarco(endo)plasmic reticulum Ca(2+)-ATPase.
Nakagawa T; Yokoe S; Asahi M
Biochem Biophys Res Commun; 2016 Apr; 472(3):523-30. PubMed ID: 26966065
[TBL] [Abstract][Full Text] [Related]
15. TSH inhibits SERCA2a and the PKA/PLN pathway in rat cardiomyocytes.
Dong J; Gao C; Liu J; Cao Y; Tian L
Oncotarget; 2016 Jun; 7(26):39207-39215. PubMed ID: 27206677
[TBL] [Abstract][Full Text] [Related]
16. A-kinase anchoring protein 5 anchors protein kinase A to mediate PLN/SERCA to reduce cardiomyocyte apoptosis induced by hypoxia and reoxygenation.
Wang Z; Zhang X; Zhu F; Zhou S; Wang Q; Wang H
Biochem Cell Biol; 2022 Apr; 100(2):162-170. PubMed ID: 35041539
[TBL] [Abstract][Full Text] [Related]
17. [Urotensin II induces hypertrophy of in vitro cultured neonatal rat cardiac myocytes].
Zuo HH; Hong JM; Guo HS; Wei JR; He YH; Li ZL
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jun; 24(6):642-5. PubMed ID: 15201078
[TBL] [Abstract][Full Text] [Related]
18. Urotensin II induces activation of NLRP3 and pyroptosis through calcineurin in cardiomyocytes.
Liang Y; Wu X; Xu M; Ding L; Li H; Wu Y
Peptides; 2021 Oct; 144():170609. PubMed ID: 34242679
[TBL] [Abstract][Full Text] [Related]
19. Effects of stachydrine on norepinephrine-induced neonatal rat cardiac myocytes hypertrophy and intracellular calcium transients.
Zhang C; Shan XL; Liao YL; Zhao P; Guo W; Wei HC; Lu R
BMC Complement Altern Med; 2014 Dec; 14():474. PubMed ID: 25488774
[TBL] [Abstract][Full Text] [Related]
20. TGR5 activation ameliorates hyperglycemia-induced cardiac hypertrophy in H9c2 cells.
Cheng KC; Chang WT; Kuo FY; Chen ZC; Li Y; Cheng JT
Sci Rep; 2019 Mar; 9(1):3633. PubMed ID: 30842472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
